Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Nov-14 Health services in the Arabian Gulf region are at a crossroads. Despite heavy investment in new hospitals, the rise in non-communicable diseases cannot be halted unless there is a whole systems approach. The region will either follow a route of reactive medicine and spiralling costs, or a preventative one, adopting technology to change the way care is delivered in the community. [image: Arab Health Magazine]
Read More
18-Nov-14 In March 2014, the Indian government started a pilot of 4,250 Swasthya Slates in six districts of the state of Jammu and Kashmir. The health kits allow doctors to diagnose and advise patients remotely, through telemedicine via technologies such as Skype and FaceTime, helping to prevent lifestyle diseases such as diabetes and cardiovascular illness. [image: VentureBeat]
Read More
17-Nov-14 Novartis researchers are seeking fresh technologies to monitor how the company’s medicines are working and being taken by patients. Chief Executive Joe Jimenez predicts this will be an integral part of running a big pharmaceutical company in the coming decade, thanks to rising demand coupled with limited budgets.
Read More
12-Nov-14 Singapore is now the birthplace of a number of promising digital health startups with its strong fundamentals. With the rise in the number of digital health startups, there has been growing interest from investors too. Venture capitalist healthcare funding has increased more than five-fold since 2011. [image: e27]
Read More
12-Nov-14 Alibaba has realised its ambition of expanding into the health sector with the launch of Alibaba Health Information Technology, in Oct-14. The newly formed unit was previously Citic 21CN, a company acquired by Alibaba earlier this year. Its drug coding system is seen as the most important asset for Alibaba. [image: Want China Times]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com